Investor
American Cancer Society BrightEdge
United States
BrightEdge is the innovation and impact investment arm of the American Cancer Society, focusing on oncology startups and patient-centric cancer care solutions.
Stage
Pre-seed–Seed
Sectors
Digital Health
Cheque
Not confirmed
Invests in
Global
Sectors
About
BrightEdge operates at the intersection of investment and innovation to define and catalyze scientific, social, and sustainable impact across the continuum of cancer care. The firm leverages a legacy in cancer research to invest in scalable solutions that address critical areas of unmet need. It provides financial investment and strategic support directly to entrepreneurs and companies. The team seeks to accelerate the commercialization of patient-centric innovations by investing in cutting-edge technology-enabled solutions.
How to approach
Submit a pitch deck through the dedicated link on the portfolio page to be considered for investment.